Mabwell’s Humira Biosimilar Approved In Indonesia

As The Denosumab Rival Embarked On Global Expansion In 2025

 
• By Urtė Fultinavičiūtė
  
Indonesia's flag pinned on the map
(Shutterstock)

More from Biosimilars

More from Products